• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险对家庭输液治疗的报销:是社区获得性耐万古霉素肠球菌发展的一个促成因素吗?

Medicare reimbursement for home infusion therapy: a contributor to the development of community acquired vancomycin-resistant enterococci?

作者信息

Herbert J R

出版信息

J Intraven Nurs. 1996 Mar-Apr;19(2):99-101.

PMID:8852170
Abstract

Vancomycin is a bacteriocidal antibiotic widely used to treat gram-positive infections, including methicillin-resistant Staphylococcus aureus. During the past 5 years, there have been increasingly frequent reports of infections caused by enterococci species resistant to vancomycin. Until recently, this was a phenomenon limited almost exclusively to the hospital. Presently, there are reports of vancomycin-resistant enterococci developing in the outpatient and home care population. The intent of this article is to present one possible explanation for this trend in the hope that further research will be stimulated.

摘要

万古霉素是一种广泛用于治疗革兰氏阳性菌感染(包括耐甲氧西林金黄色葡萄球菌感染)的杀菌性抗生素。在过去5年中,耐万古霉素肠球菌引起感染的报告日益频繁。直到最近,这种现象几乎仅局限于医院。目前,有报告称在门诊和家庭护理人群中也出现了耐万古霉素肠球菌。本文旨在对这一趋势提出一种可能的解释,以期激发进一步的研究。

相似文献

1
Medicare reimbursement for home infusion therapy: a contributor to the development of community acquired vancomycin-resistant enterococci?医疗保险对家庭输液治疗的报销:是社区获得性耐万古霉素肠球菌发展的一个促成因素吗?
J Intraven Nurs. 1996 Mar-Apr;19(2):99-101.
2
Antimicrobial resistance in gram-positive bacteria.革兰氏阳性菌中的抗菌药物耐药性。
Am J Med. 2006 Jun;119(6 Suppl 1):S11-9; discussion S62-70. doi: 10.1016/j.amjmed.2006.03.012.
3
Antimicrobial resistance in gram-positive bacteria.革兰氏阳性菌中的抗菌药物耐药性。
Am J Infect Control. 2006 Jun;34(5 Suppl 1):S11-9; discussion S64-73. doi: 10.1016/j.ajic.2006.05.220.
4
Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.未来十年的超级细菌;2010年金黄色葡萄球菌、肠球菌属和铜绿假单胞菌的多重耐药性及治疗前景
Curr Opin Microbiol. 2007 Oct;10(5):436-40. doi: 10.1016/j.mib.2007.07.004. Epub 2007 Aug 30.
5
[Vancomycin resistant enterococci in the Netherlands].[荷兰的耐万古霉素肠球菌]
Ned Tijdschr Geneeskd. 2004 May 1;148(18):878-82.
6
A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.用于复杂皮肤感染以及耐甲氧西林金黄色葡萄球菌和肠球菌的现有及研究性抗生素的比较
J Drugs Dermatol. 2007 Jan;6(1):97-103.
7
[Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].[对从医院获得性感染或社区获得性感染患者中分离出的革兰氏阳性菌的监测]
Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):365-74.
8
Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.耐多药葡萄球菌和肠球菌的流行病学及耐药问题。
Clin Microbiol Infect. 2009 Mar;15(3):224-31. doi: 10.1111/j.1469-0691.2009.02739.x.
9
[An alarming problem in the therapy of infective endocarditis: the development of antibiotic-resistant strains].[感染性心内膜炎治疗中的一个警示问题:抗生素耐药菌株的出现]
Ital Heart J Suppl. 2005 Mar;6(3):121-7.
10
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.利奈唑胺与万古霉素治疗儿童耐革兰氏阳性菌感染的比较
Pediatr Infect Dis J. 2003 Aug;22(8):677-86. doi: 10.1097/01.inf.0000078160.29072.42.